MELAS Syndrome and Refeeding Syndrome in Pediatrics: A Case Report with A Fatal Outcome

Main Article Content

Erika Patricia Ortega Bonilla
Nancy Jiménez Paniagua

Abstract

MELAS syndrome (mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes) is one of the most severe and complex mitochondrial diseases, characterized by its clinical heterogeneity and progressive course. We present the case of an 8-year-old pediatric patient with a confirmed diagnosis of MELAS, who experienced severe gastrointestinal episodes, refeeding syndrome, and metabolic complications, culminating in a fatal outcome. Through clinical analysis and a review of the literature, we emphasize the importance of a multidisciplinary approach that considers both neurological manifestations and associated digestive and nutritional complications.This report highlights the need for early surveillance protocols, comprehensive metabolic support management, and timely recognition of risks such as refeeding syndrome. It also underscores the urgent need to strengthen research and clinical guidelines adapted to the pediatric and hospital context in resource-limited settings.

Article Details

How to Cite
Ortega Bonilla, Erika Patricia, and Nancy Jiménez Paniagua. 2026. “MELAS Syndrome and Refeeding Syndrome in Pediatrics: A Case Report With A Fatal Outcome”. International Journal of Medical Science and Clinical Research Studies 6 (05):997-1000. https://doi.org/10.47191/ijmscrs/v6-i5-31.
Section
Articles

References

I. Zhou J, Li Y, Xu H. Biomarkers in mitochondrial encephalomyopathies: pathophysiology and clinical translation. Biomolecules. 2024;14(8):1524.

II. Zheng X, Wang J, Chen L. Pediatric mitochondrial diseases: advances in diagnosis and management. Front Neurosci. 2022;16:1028762.

III. García-Cazorla Á, Jou C, O’Callaghan MM. Gastrointestinal complications in mitochondrial disorders: clinical and therapeutic perspectives. Eur J Intern Med. 2021;82:77-84.

IV. Orphanet Journal of Rare Diseases. Global prevalence of mitochondrial disorders. Orphanet J Rare Dis. 2024.

V. Li F, Zhou X, Zhang L, Zhao H. MELAS syndrome presenting with diffuse posterior leukoencephalopathy: case report and review. BMC Neurol. 2022;22(1):151.

VI. da Silva JSV, Seres DS, Sabino K, Adams SC, Berdahl GJ, Citty SW, et al. ASPEN consensus recommendations for refeeding syndrome. JPEN J Parenter Enteral Nutr. 2020;44(1):12-40.

VII. Martínez-Campos S, Hernández-Pérez MA, López-Gómez L. Síndrome MELAS en pediatría: reporte de caso. Rev Fac Med (Méx). 2019;62(3):187-192.

VIII. Mehanna H, Moledina J, Travis J. Refeeding syndrome: what it is, and how to prevent and treat it. BMJ. 2024;385:e072989.

IX. López-Gallardo E, et al. Nutritional risk and metabolic instability in mitochondrial diseases. Clin Nutr. 2023.

X. Crook MA, Hally V, Panteli JV. The importance of the refeeding syndrome. Nutrition. 2022;103:111730.

XI. Zhou Y, Lin Y, Luo T. Diffuse posterior leukoencephalopathy in MELAS: clinical relevance and imaging features. Front Neurol. 2022;13:894563.

XII. Rodríguez-López A, Castillo-González M, Torres D. Síndrome MELAS en pediatría: reporte de caso colombiano. Rev Colomb Pediatr Neonatol. 2020;37(2):121-126.

XIII. López-Gallardo E, et al. Mitochondrial dysfunction and nutritional vulnerability in pediatric MELAS. JIMD Rep. 2023.

XIV. Xu S, Jiang J, Chang L, Zhang B, Zhu X, Niu F. Multisystem clinicopathologic and genetic analysis of MELAS. Orphanet J Rare Dis [Internet]. 2024 [citado 2026 May 11]. Disponible en: http://dx.doi.org/10.1186/s13023-024-035114